Inozyme Pharma
INZY
#7941
Rank
HK$1.56 B
Marketcap
HK$24.33
Share price
-8.89%
Change (1 day)
-2.62%
Change (1 year)

EPS for Inozyme Pharma (INZY)

EPS in 2023 (TTM): -HK$12.15

According to Inozyme Pharma's latest financial reports the company's current EPS (TTM) is -HK$12.07. In 2022 the company made an earnings per share (EPS) of -HK$14.71 a decrease over its 2021 EPS that were of -HK$13.78.

EPS history for Inozyme Pharma from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$12.15-17.44%
2022-HK$14.716.78%
2021-HK$13.78-41.04%
2020-HK$23.37130.75%
2019-HK$10.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.97 40.65%๐Ÿ‡บ๐Ÿ‡ธ USA